References

1. Bazell, R., in The New Republic. 1991. Biotech bingo, p 10-12, April 18.

2. OTA, report, Biotechnology in a global economy. In OTA-BA-494, B. 1991, US Office of Technology Assessment. 3-98.

3. U.S. Congress, H.O.R., Office of Technology Assessment, New Developments in Biotechnology: U.S. Investment in Biotechnology, OTA-BA-360. 1988.

4. National Institute of Health, Summary Budget report. 2001, NIH, USPHS.

5. Report, E.-Y., Convergence, the biotechnology report: from thought to finish. 2000.

6. Ward, S.J., Impact of genomics in drug discovery. Biotechniques, 2001. 31(3): 626, 628, 630, passim.

7. Wickelgren, I., Mining the genome for drugs. Science, 1999. 285(5430): 998-1001.

8. Ohlstein, E.H., R.R. Ruffolo, Jr., and J.D. Elliott, Drug discovery in the next millennium. Annu Rev Pharmacol Toxicol, 2000. 40:177-91.

9. Emilien, G., M. Ponchon, C. Caldas, O. Isacson, and J.M. Maloteaux, Impact of genomics on drug discovery and clinical medicine. Qjm, 2000. 93(7): 391-423.

0 0

Post a comment